• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西男男性行为者和跨性别女性中,针对每日口服HIV暴露前预防用药的间接依从性测量方法的效果评估

Performance of indirect adherence measures for daily oral pre-exposure prophylaxis for HIV among adolescent men who have sex with men and transgender women in Brazil.

作者信息

Zeballos Diana, Magno Laio, Soares Fabiane, Pinto Junior Jony Arrais, Amorim Leila, Greco Dirceu, Grangeiro Alexandre, Dourado Inês

机构信息

Instituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador, Bahia, Brazil.

Departamento de Ciências da Vida, Universidade do Estado da Bahia, Salvador, Bahia, Brazil.

出版信息

PLoS One. 2024 Dec 31;19(12):e0310861. doi: 10.1371/journal.pone.0310861. eCollection 2024.

DOI:10.1371/journal.pone.0310861
PMID:39739641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11687640/
Abstract

BACKGROUND

Consistent monitoring of PrEP adherence with accurate measurement tools at point-of-care could greatly contribute to reaching adolescents with poor adherence. We aimed to assess the performance of indirect adherence measures to oral PrEP among adolescent men who have sex with men (AMSM) and adolescent transgender women (ATGW).

METHODS

PrEP15-19 is a prospective, multicenter, PrEP demonstration cohort study that includes AMSM and ATGW aged 15-19 in three Brazilian cities. A diagnostic accuracy study was conducted using tenofovir-diphosphate (TFV-DP) concentrations in dried blood spots as the reference standard, along with three index tests: medication possession ratio (MPR), pill count, and self-report. We calculated the area under the curve (AUC) for protective TFV-DP levels (≥800 fmol/punch) and sensitivity (SE) and specificity (SP) for established cutoff points.

RESULTS

We included 302 samples from 188 participants. Most of participants were AMSM (78.7%), aged 18-19 years (80.3%), and non-whites (72.9%). The AUC was 0.59 for MPR, 0.69 for pill count, and 0.75 for self-report. When combining MPR and self-report, the AUC increased to 0.77. Sensitivity was high for the cutoff points identified by the Youden index, 80% for MPR, 92% for self-report, and 97% for pill count. However, specificities were low 40%, 46%, and 38%, respectively.

CONCLUSIONS

Indirect measures were able to discriminate adolescents with good adherence. However, their performance in identifying those with low adherence might be limited, suggesting that it is necessary to initiate adherence interventions when there is no evidence of perfect adherence. Combining measures can provide wider information on adherence.

摘要

背景

在医疗现场使用准确的测量工具持续监测暴露前预防(PrEP)的依从性,对于接触依从性差的青少年有很大帮助。我们旨在评估男男性行为青少年(AMSM)和跨性别女性青少年(ATGW)中口服PrEP间接依从性测量方法的性能。

方法

PrEP15 - 19是一项前瞻性、多中心的PrEP示范队列研究,纳入了巴西三个城市中年龄在15 - 19岁的AMSM和ATGW。以干血斑中的二磷酸替诺福韦(TFV - DP)浓度作为参考标准进行诊断准确性研究,同时采用三项指标检测:药物持有率(MPR)、药片计数和自我报告。我们计算了保护性TFV - DP水平(≥800 fmol/打孔)的曲线下面积(AUC)以及既定切点的敏感性(SE)和特异性(SP)。

结果

我们纳入了188名参与者的302个样本。大多数参与者为AMSM(78.7%),年龄在18 - 19岁(80.3%),且为非白人(72.9%)。MPR的AUC为0.59,药片计数的AUC为0.69,自我报告的AUC为0.75。当将MPR和自我报告相结合时,AUC增至0.77。对于约登指数确定的切点,敏感性较高,MPR为80%,自我报告为92%,药片计数为97%。然而,特异性较低,分别为40%、46%和38%。

结论

间接测量方法能够区分依从性良好的青少年。然而,它们在识别依从性低的青少年方面的表现可能有限,这表明在没有完美依从证据时就有必要启动依从性干预措施。综合多种测量方法可以提供更广泛的依从性信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e151/11687640/07fbdaeb60f3/pone.0310861.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e151/11687640/07fbdaeb60f3/pone.0310861.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e151/11687640/07fbdaeb60f3/pone.0310861.g001.jpg

相似文献

1
Performance of indirect adherence measures for daily oral pre-exposure prophylaxis for HIV among adolescent men who have sex with men and transgender women in Brazil.巴西男男性行为者和跨性别女性中,针对每日口服HIV暴露前预防用药的间接依从性测量方法的效果评估
PLoS One. 2024 Dec 31;19(12):e0310861. doi: 10.1371/journal.pone.0310861. eCollection 2024.
2
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.男男性行为者和跨性别女性中 HIV 暴露前预防间接依从措施的表现:来自 PrEP Brasil 研究的结果。
PLoS One. 2019 Aug 20;14(8):e0221281. doi: 10.1371/journal.pone.0221281. eCollection 2019.
3
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.高暴露前预防药物(PrEP)的使用率和 HIV 感染风险男男性行为者和跨性别女性的早期用药依从性:PrEP Brasil 示范项目。
J Int AIDS Soc. 2017 Apr 6;20(1):21472. doi: 10.7448/IAS.20.1.21472.
4
Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.在泰国,为青少年男男性行为者和有感染艾滋病毒风险的跨性别女性提供青少年友好服务和手机应用程序,以促进其坚持使用暴露前预防措施:一项随机对照试验。
J Int AIDS Soc. 2020 Sep;23 Suppl 5(Suppl 5):e25564. doi: 10.1002/jia2.25564.
5
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.《PrEP Brasil 中男男性行为者和跨性别女性人群使用暴露前预防的保留率、参与率和坚持率:一项示范研究的 48 周结果》
Lancet HIV. 2018 Mar;5(3):e136-e145. doi: 10.1016/S2352-3018(18)30008-0. Epub 2018 Feb 18.
6
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.与市级和社区性健康服务相结合的HIV感染暴露前预防
JAMA Intern Med. 2016 Jan;176(1):75-84. doi: 10.1001/jamainternmed.2015.4683.
7
Adherence, Safety, and Feasibility of HIV Pre-Exposure Prophylaxis Among Adolescent Men Who Have Sex With Men and Transgender Women in Brazil (PrEP1519 Study).巴西男男性行为青少年和跨性别女性中HIV暴露前预防的依从性、安全性和可行性(PrEP1519研究)
J Adolesc Health. 2023 Dec;73(6S):S33-S42. doi: 10.1016/j.jadohealth.2023.09.005.
8
Concordance between daily diary reported pre-exposure prophylaxis intake and intraerythrocytic tenofovir diphosphate in the Amsterdam Pre-exposure Prophylaxis demonstration project.阿姆斯特丹暴露前预防示范项目中,每日日记报告的暴露前预防用药摄入量与红细胞内替诺福韦二磷酸之间的一致性。
AIDS. 2024 Jul 1;38(8):1248-1256. doi: 10.1097/QAD.0000000000003889. Epub 2024 Mar 20.
9
Same-Day Initiation of Oral Pre-Exposure Prophylaxis is High Among Adolescent Men Who Have Sex With Men and Transgender Women in Brazil.在巴西,男男性行为者和跨性别女性青少年中,口服暴露前预防的当日启动率很高。
J Adolesc Health. 2023 Dec;73(6S):S26-S32. doi: 10.1016/j.jadohealth.2023.09.002.
10
Adherence and HIV Protection Thresholds for Emtricitabine and Tenofovir Disoproxil Fumarate Preexposure Prophylaxis among Cisgender Women: A Systematic Review.顺性别女性中恩曲他滨和富马酸替诺福韦二吡呋酯暴露前预防的依从性和 HIV 保护阈值:系统评价。
Curr HIV/AIDS Rep. 2024 Oct;21(5):264-281. doi: 10.1007/s11904-024-00705-0. Epub 2024 Aug 9.

引用本文的文献

1
Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross-sectional study.巴西男男性行为者和跨性别女性中青少年对事件驱动型和长效注射用暴露前预防药物的知晓率及使用意愿:一项横断面研究
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26479. doi: 10.1002/jia2.26479.

本文引用的文献

1
Building bridges to care: the experience of peer navigation in enabling linkage to PrEP for adolescent men who have sex with men and transgender women.搭建关怀桥梁:同伴导航助力男男性行为青少年和跨性别女性与暴露前预防建立联系的经验
Cad Saude Publica. 2023 Mar 27;39Suppl 1(Suppl 1):e00176821. doi: 10.1590/0102-311XEN176821. eCollection 2023.
2
Interdisciplinarity in HIV prevention research: the experience of the PrEP1519 study protocol among adolescent MSM and TGW in Brazil.HIV 预防研究中的跨学科性:巴西青少年男男性行为者和跨性别女性中 PrEP1519 研究方案的经验。
Cad Saude Publica. 2023 Mar 27;39Suppl 1(Suppl 1):e00143221. doi: 10.1590/0102-311XEN143221. eCollection 2023.
3
Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis.
停止使用、不规范使用和重新开始口服 HIV 暴露前预防:全球系统评价和荟萃分析。
Lancet HIV. 2022 Apr;9(4):e254-e268. doi: 10.1016/S2352-3018(22)00030-3.
4
Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya.了解肯尼亚年轻女性的暴露前预防用药依从性。
J Acquir Immune Defic Syndr. 2022 Mar 1;89(3):251-260. doi: 10.1097/QAI.0000000000002876.
5
Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.采纳和使用口腔暴露前预防指南:全球概述和预测研究。
Lancet HIV. 2021 Aug;8(8):e502-e510. doi: 10.1016/S2352-3018(21)00127-2. Epub 2021 Jul 12.
6
Real-Time Monitoring and Point-of-Care Testing: A Review of the Current Landscape of PrEP Adherence Monitoring.实时监测与即时检测:暴露前预防依从性监测的当前现状综述
Patient Prefer Adherence. 2021 Feb 5;15:259-269. doi: 10.2147/PPA.S248696. eCollection 2021.
7
HIV Pre-Exposure Prophylaxis for Conception Among HIV Serodiscordant Couples in the United States: A Cohort Study.HIV 血清不一致的夫妇中用于受孕的 HIV 暴露前预防:一项队列研究。
AIDS Patient Care STDS. 2020 Jul;34(7):295-302. doi: 10.1089/apc.2020.0005.
8
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.替诺福韦艾拉酚胺治疗后干血斑中细胞内替诺福韦二磷酸和恩曲他滨三磷酸:TAF-DBS 研究。
J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):323-330. doi: 10.1097/QAI.0000000000002354.
9
Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.男男性行为者和跨性别女性中 HIV 暴露前预防间接依从措施的表现:来自 PrEP Brasil 研究的结果。
PLoS One. 2019 Aug 20;14(8):e0221281. doi: 10.1371/journal.pone.0221281. eCollection 2019.
10
Comparing Self-Report Pre-Exposure Prophylaxis Adherence Questions to Pharmacologic Measures of Recent and Cumulative Pre-Exposure Prophylaxis Exposure.比较自我报告的暴露前预防依从性问题与近期和累积暴露前预防暴露的药理学测量方法。
Front Pharmacol. 2019 Jul 5;10:721. doi: 10.3389/fphar.2019.00721. eCollection 2019.